Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Sildenafil vs Tadalafil for Erectile Dysfunction

Comparative Efficacy

  • The American Urological Association suggests that both sildenafil and tadalafil are equally effective first-line treatments for erectile dysfunction, with the primary difference being tadalafil's longer duration of action (up to 36 hours vs 4-5 hours) 1, 2
  • Success rates for sexual intercourse: Sildenafil achieves 69% success (range 52-85%) versus placebo 35.5%, while tadalafil achieves 69% success (range 50-85%) versus placebo 33% 2
  • Erection improvement: Both agents improve erections in 73-88% of patients compared to 26-32% with placebo, according to the Annals of Internal Medicine 2

Key Pharmacological Differences

  • The maximum frequency of sildenafil is once daily 1
  • The nitrate washout period for sildenafil is at least 24 hours, and for tadalafil, it is at least 24-48 hours due to its longer half-life 3, 4

Dose-Response Relationships

  • Sildenafil shows dose-related improvement seen from 25 mg to 50 mg, but less additional benefit from 50 mg to 100 mg, as reported by the Annals of Internal Medicine 2
  • Tadalafil has no significant dose-response difference between 5 mg, 10 mg, and 20 mg for on-demand dosing, according to the Annals of Internal Medicine 2

Adverse Effect Profiles

  • Common side effects of both agents include headache, flushing, dyspepsia, nasal congestion, myalgia, visual disturbances, and dizziness, with a low rate of serious adverse events (<2%) 1, 3, 5

Special Populations

  • Both agents are effective in patients with diabetes, though response is less robust than in the general population, with the American Urological Association recommending their use 1
  • Both agents are effective but response is diminished compared to general ED population in post-prostatectomy patients, according to the Journal of Urology 1

Critical Safety Considerations

  • Absolute contraindication: Never use with nitrates due to severe hypotension risk, as stated by Praxis Medical Insights 4
  • Cardiovascular assessment: ED diagnosis provides opportunity to evaluate cardiovascular risk factors, according to the Journal of Urology 1

Optimization Strategies

  • Titrate dose: Start at recommended dose and adjust based on efficacy and tolerability, as recommended by the Journal of Urology 1
  • Adequate trial: Ensure 4-8 attempts at proper dosing before declaring treatment failure, according to Praxis Medical Insights 3

REFERENCES

1

erectile dysfunction: aua guideline. [LINK]

The Journal of urology, 2018

3

Comparative Efficacy of Phosphodiesterase Type 5 Inhibitors [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Transitioning from Tadalafil to Sildenafil [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Tadalafil Dosing and Efficacy for Erectile Dysfunction [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025